# Pliant Therapeutics (stock symbol: PLRX) Logo in transparent PNG and SVG formats

## Pliant Therapeutics Logo large

### Pliant Therapeutics Logo large Download PNG (145.21 KB)

![Pliant Therapeutics Logo large Download PNG (145.21 KB)](/img/orig/PLRX_BIG-cc020a53.png)

### Pliant Therapeutics Logo large Download SVG (21.94 KB)

![Pliant Therapeutics Logo large Download SVG (21.94 KB)](/img/orig/PLRX_BIG-f25721f0.svg)

## Pliant Therapeutics Logo icon format

### Pliant Therapeutics Logo icon format Download PNG (228.73 KB)

![Pliant Therapeutics Logo icon format Download PNG (228.73 KB)](/img/orig/PLRX-85066dcf.png)

### Pliant Therapeutics Logo icon format Download SVG (20.89 KB)

![Pliant Therapeutics Logo icon format Download SVG (20.89 KB)](/img/orig/PLRX-f55dbab7.svg)

## Pliant Therapeutics Logo large for dark backgrounds

### Pliant Therapeutics Logo large for dark backgrounds Download PNG (55.65 KB)

![Pliant Therapeutics Logo large for dark backgrounds Download PNG (55.65 KB)](/img/orig/PLRX_BIG.D-46b99fa2.png)

### Pliant Therapeutics Logo large for dark backgrounds Download SVG (21.47 KB)

![Pliant Therapeutics Logo large for dark backgrounds Download SVG (21.47 KB)](/img/orig/PLRX_BIG.D-77aacc9d.svg)

## Pliant Therapeutics Logo icon format for dark backgrounds

### Pliant Therapeutics Logo icon format for dark backgrounds Download PNG (80.62 KB)

![Pliant Therapeutics Logo icon format for dark backgrounds Download PNG (80.62 KB)](/img/orig/PLRX.D-2dd5a205.png)

### Pliant Therapeutics Logo icon format for dark backgrounds Download SVG (20.45 KB)

![Pliant Therapeutics Logo icon format for dark backgrounds Download SVG (20.45 KB)](/img/orig/PLRX.D-207951a5.svg)

## About Pliant Therapeutics

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avÃŸ6 and avÃŸ1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avÃŸ1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

1. Website domain: pliantrx.com
2. Employees: 110
3. Marketcap: $1.66 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
